Exploring the mechanism of XieBai San in treating liver injury based on network pharmacology and experimental verification
Abstract
The XieBai San (XBS) formula contains SangbaiPi (Cortex Mori), Digupi (Cortex Lycii), and Gancao (Radix Glycyrrhizae). Some studies have shown that XBS exerts a healing impact on liver damage. However, the specific active components and the underlying mechanism are still not fully understood. To explore this phenomenon, we administered a 0.2% CCl4 oil solution to mice to elicit acute liver damage, and then XBS was given by gavage to mice. The results indicated that XBS exhibited a beneficial impact on liver injury. TCMSP, PubChem, SwissTargetPrediction, and GeneCards and DisGeNET databases were used to screen the active components of Cortex Mori, Cortex Lycii, and Radix Glycyrrhizae in XBS and their therapeutic targets for liver injury. Venn diagrams was utilized to identify the intersecting genes and the STRING database to explore protein-protein interactions. PPI networks and drug-component-target networks were constructed through Cytoscape software. Additionally, GO and KEGG enrichment studies were performed utilizing the DAVID platform. Subsequently, molecular docking validation was carried out using AutoDockTools version 1.5.6. The main active components of XBS were quercetin, jaranol, isorhamnetin, sitosterol, and kaempferol. The key targets were AKT1, EGFR, ESR1, PIK3CA, and PIK3R1. The predicted key targets were involved in positive regulation of peptide-bound serine phosphorylation and other biological processes that can restore liver function, anti-inflammatory response, and antioxidant stress to treat liver injury. XBS exerts its therapeutic effect on liver injury through multiple targets and mechanisms.
References
1. Okubo S, Miyamoto M, Ito D, Takami K, Ashida K. Albumin and apolipoprotein H mRNAs in human plasma as potential clinical biomarkers of liver injury: analyses of plasma liver-specific mRNAs in patients with liver injury. Biomarkers. 2016;21(4):353-62.
2. Zhao T, Yu Z, Zhou L, Wang X, Hui Y, Mao L, Fan X, Wang B, Zhao X, Sun C. Regulating Nrf2-GPx4 axis by bicyclol can prevent ferroptosis in carbon tetrachloride-induced acute liver injury in mice. Cell Death Discov. 2022 Sep 7;8(1):380.
3. Zhao CQ, Zhou Y, Ping J, Xu LM. Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. J Integr Med. 2014 Sep;12(5):401-8.
4. Xiang D, Zou J, Zhu X, Chen X, Luo J, Kong L, Zhang H. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling. Phytomedicine. 2020 Nov;78:153294.
5. Zhao A, Guo C, Wang L, Chen S, Xu Q, Cheng J, Zhang J, Jiang J, Di J, Zhang H, Chen F, Su J, Jiang L, Liu L, Liu Y, Liu A. Xiebai San alleviates acute lung injury by inhibiting the phosphorylation of the ERK/Stat3 pathway and regulating multiple metabolisms. Phytomedicine. 2024 Jun;128:155397.
6. Zhao A, Su J, Xu Q, Zhang J, Jiang J, Chen S, Cheng J, Chen C, Wang L, Di J, Liu X, Jiang L, Liu L, Liu Y, Liu A, Guo C. Elucidation of anti-pneumonia pharmacodynamic material basis and potential mechanisms of Xiebai San by combining spectrum-efficacy relationship and surface plasmon resonance. J Ethnopharmacol. 2024 Dec 5;335:118609.
7. Jiashuo WU, Fangqing Z, Zhuangzhuang LI, Weiyi J, Yue S. Integration strategy of network pharmacology in Traditional Chinese Medicine: a narrative review. J Tradit Chin Med. 2022 Jun;42(3):479-486.
8. Wei Yuanyuan, Fan Yimeng, Yuan Yanyan, et al.Protective Effect of Aqueous Extract of Yinshanlian on Acute Liver Injury Induced by Carbon Tetrachloride in Mice[J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(07): 2333-2342.
9. RU J, LI P, WANG J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines [J]. J Cheminform, 2014, 6: 13.
10. KIM S, CHEN J, CHENG T, et al. PubChem 2023 update [J]. Nucleic Acids Research, 2022, 51(D1): D1373-D80.
11. DAINA A, MICHIELIN O, ZOETE V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules [J]. Nucleic Acids Research, 2019, 47(W1): W357-W64.
12. Luo W, Deng J, He J, Yin L, You R, Zhang L, Shen J, Han Z, Xie F, He J, Guan Y. Integration of molecular docking, molecular dynamics and network pharmacology to explore the multi-target pharmacology of fenugreek against diabetes. J Cell Mol Med. 2023 Jul;27(14):1959-1974.
13. Liu T, Wang J, Tong Y, Wu L, Xie Y, He P, Lin S, Hu X. Integrating network pharmacology and animal experimental validation to investigate the action mechanism of oleanolic acid in obesity. J Transl Med. 2024 Jan 21;22(1):86.
14. Ji L, Song T, Ge C, Wu Q, Ma L, Chen X, Chen T, Chen Q, Chen Z, Chen W. Identification of bioactive compounds and potential mechanisms of scutellariae radix-coptidis rhizoma in the treatment of atherosclerosis by integrating network pharmacology and experimental validation. Biomed Pharmacother. 2023 Sep;165:115210.
15. Yu S, Fan C, Li Y, Pei H, Tian Y, Zuo Z, Wang Z, Liu C, Zhao X, Wang Z. Network pharmacology and experimental verification to explore the anti-migraine mechanism of Yufeng Ningxin Tablet. J Ethnopharmacol. 2023 Jun 28;310:116384.
16. Althagafy HS, Ali FEM, Hassanein EHM, Mohammedsaleh ZM, Kotb El-Sayed MI, Atwa AM, Sayed AM, Soubh AA. Canagliflozin ameliorates ulcerative colitis via regulation of TLR4/MAPK/NF-κB and Nrf2/PPAR-γ/SIRT1 signaling pathways. Eur J Pharmacol. 2023 Dec 5;960:176166.
17. Liu T, Li Y, Wang L, Zhang X, Zhang Y, Gai X, Chen L, Liu L, Yang L, Wang B. Network pharmacology-based exploration identified the antiviral efficacy of Quercetin isolated from mulberry leaves against enterovirus 71 via the NF-κB signaling pathway. Front Pharmacol. 2023 Sep 19;14:1260288.
18. Noor F, Asif M, Ashfaq UA, Qasim M, Tahir Ul Qamar M. Machine learning for synergistic network pharmacology: a comprehensive overview. Brief Bioinform. 2023 May 19;24(3):bbad120.
19. Liu P, Hao J, Zhao J, Zou R, Han J, Tian J, Liu W, Wang H. Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Therapeutic Effects of Capsaicin on Lipopolysaccharide-Induced Acute Lung Injury. Mediators Inflamm. 2022 Jan 30;2022:9272896.
20. Pu S, Zhang J, Ren C, Zhou H, Wang Y, Wu Y, Yang S, Cao F, Zhou H. Montelukast prevents mice against carbon tetrachloride- and methionine-choline deficient diet-induced liver fibrosis: Reducing hepatic stellate cell activation and inflammation. Life Sci. 2023 Jul 15;325:121772.
21. Xian S, Yang Y, Nan N, Fu X, Shi J, Wu Q, Zhou S. Inhibition of mitochondrial ROS-mediated necroptosis by Dendrobium nobile Lindl. alkaloids in carbon tetrachloride induced acute liver injury. J Ethnopharmacol. 2024 Aug 10;330:118253.
22. Chen M, Zhong G, Liu M, He H, Zhou J, Chen J, Zhang M, Liu Q, Tong G, Luan J, Zhou H. Integrating network analysis and experimental validation to reveal the mitophagy-associated mechanism of Yiqi Huoxue (YQHX) prescription in the treatment of myocardial ischemia/reperfusion injury. Pharmacol Res. 2023 Mar;189:106682.
23. Zhang Q, Gao Y, Wang Y, Liu DH, Liu CF, Zhong LY, Liang J, Tian WW, Hong TT, Bai J, DU SY. [Particle size of “Cuo San” of famous classical formulas and decoction process with Xiebai San for example]. Zhongguo Zhong Yao Za Zhi. 2020 Feb;45(4):878-883. Chinese.
24. Khan Z, Nath N, Rauf A, Emran TB, Mitra S, Islam F, Chandran D, Barua J, Khandaker MU, Idris AM, Wilairatana P, Thiruvengadam M. Multifunctional roles and pharmacological potential of β-sitosterol: Emerging evidence toward clinical applications. Chem Biol Interact. 2022 Sep 25;365:110117.
25. Li H, Weng Q, Gong S, Zhang W, Wang J, Huang Y, Li Y, Guo J, Lan T. Kaempferol prevents acetaminophen-induced liver injury by suppressing hepatocyte ferroptosis via Nrf2 pathway activation. Food Funct. 2023 Feb 21;14(4):1884-1896.
26. Yang X, Wang H, Shen C, Dong X, Li J, Liu J. Effects of isorhamnetin on liver injury in heat stroke-affected rats under dry-heat environments via oxidative stress and inflammatory response. Sci Rep. 2024 Mar 29;14(1):7476.
27. Thapa R, Afzal O, Alfawaz Altamimi AS, Goyal A, Almalki WH, Alzarea SI, Kazmi I, Jakhmola V, Singh SK, Dua K, Gilhotra R, Gupta G. Galangin as an inflammatory response modulator: An updated overview and therapeutic potential. Chem Biol Interact. 2023 Jun 1;378:110482.
28. Zhao Y, Li B, Deng H, Zhang C, Wang Y, Chen L, Teng H. Galangin Alleviates Alcohol-Provoked Liver Injury Associated with Gut Microbiota Disorder and Intestinal Barrier Dysfunction in Mice. J Agric Food Chem. 2024 Oct 9;72(40):22336-22348.
29. Peng Y, Zhu G, Ma Y, Huang K, Chen G, Liu C, Tao Y. Network Pharmacology-Based Prediction and Pharmacological Validation of Effects of Astragali Radix on Acetaminophen-Induced Liver Injury. Front Med (Lausanne). 2022 Jul 4; 9: 697644.
30. Hu B, Zou T, Qin W, Shen X, Su Y, Li J, Chen Y, Zhang Z, Sun H, Zheng Y, Wang CQ, Wang Z, Li TE, Wang S, Zhu L, Wang X, Fu Y, Ren X, Dong Q, Qin LX. Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3-ABCB1 Signaling in Hepatocellular Carcinoma. Cancer Res. 2022 Oct 17;82(20):3845-3857.
31. Cao Y, Wang C, Dong L. Exploring the Mechanism of White Peony in the Treatment of Lupus Nephritis Based on Network Pharmacology and Molecular Docking. Arch Esp Urol. 2023 Mar;76(2):123-131.
32. González L, Díaz ME, Miquet JG, Sotelo AI, Dominici FP. Growth Hormone Modulation of Hepatic Epidermal Growth Factor Receptor Signaling. Trends Endocrinol Metab. 2021 Jun;32(6):403-414.
33. Kamei H, Onishi Y, Nakamura T, Ishigami M, Hamajima N. Role of cytokine gene polymorphisms in acute and chronic kidney disease following liver transplantation. Hepatol Int. 2016 Jul;10(4):665-72.
Copyright (c) 2024 Tingting Hou, Chunjie Yang, You Lv, Yongfeng Ma, Runhua Li, Mingli Shang, Qianwen Zhang, Cheng Luo, Huiqin Qian, Xiaoyue Lou
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright on all articles published in this journal is retained by the author(s), while the author(s) grant the publisher as the original publisher to publish the article.
Articles published in this journal are licensed under a Creative Commons Attribution 4.0 International, which means they can be shared, adapted and distributed provided that the original published version is cited.
Submit a Paper
